© 2022 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Alan Skarbnik, MD, reviews the case of a 60-year-old man with follicular lymphoma and provides a discussion on treatment considerations and challenges.
October 11th 2021
Alan Skarbnik, MD, presents the case of a 60-year-old man with newly diagnosed follicular lymphoma.
A key opinion leader discusses the considerations in choosing induction and maintenance therapy options for follicular lymphoma.
Dr. Alan Skarbnik reviews the use of obinutuzumab-based therapies for follicular lymphoma and highlights data from a phase III study.
An expert describes typical monitoring strategies in follicular lymphoma.
Alan Skarbnik, MD, explains early relapse in follicular lymphoma and the available treatment options.
An oncologist ruminates on emerging treatment options in follicular lymphoma and offers some clinical pearls.